Business Segments · Goodwill, Acquired During Period

Health Sciences — Goodwill, Acquired During Period

Year-over-year, this metric declined by 100.0%, from $17.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Health Sciences — Goodwill, Acquired During Period shows a downward trend with a -100.0% CAGR.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2025

How to read this metric

Higher values indicate aggressive inorganic growth and strategic investment, while zero or low values suggest a focus on organic growth or a pause in M&A activity.

Detailed definition

This metric tracks the specific amount of goodwill recognized on the balance sheet resulting from business combinations...

Peer comparison

Comparable to 'Acquisitions' or 'Goodwill Additions' reported by other IT services firms when they expand their specialized healthcare service offerings.

Metric ID: ctsh_segment_health_sciences_goodwill_acquired_during_period

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$84.00M$2.00M$15.00M$68.00M$0.00
YoY Change-97.6%+650.0%+353.3%-100.0%
Range$0.00$84.00M
CAGR-100.0%
Avg YoY Growth+201.4%
Median YoY Growth+127.9%

Frequently Asked Questions

What is Cognizant's health sciences — goodwill, acquired during period?
Cognizant (CTSH) reported health sciences — goodwill, acquired during period of $0.00 in Q4 2025.
How has Cognizant's health sciences — goodwill, acquired during period changed year-over-year?
Cognizant's health sciences — goodwill, acquired during period decreased by 100.0% year-over-year, from $17.00M to $0.00.
What is the long-term trend for Cognizant's health sciences — goodwill, acquired during period?
Over 4 years (2021 to 2025), Cognizant's health sciences — goodwill, acquired during period has grown at a -100.0% compound annual growth rate (CAGR), from $84.00M to $0.00.
What does health sciences — goodwill, acquired during period mean?
The value of goodwill added to the Health Sciences segment through new company acquisitions during the current year.